Zonipraz Tablet contains Pantoprazole 40 mg, a proton pump inhibitor used to reduce gastric acid secretion. It is indicated for the treatment of gastroesophageal reflux disease (GERD), erosive esophagitis, Zollinger-Ellison syndrome, and other conditions involving excessive stomach acid production. Pantoprazole acts by selectively inhibiting the H+/K+ ATPase enzyme system at the secretory surface of gastric parietal cells, thereby suppressing the final step of acid production. This results in decreased gastric acidity, promoting healing of acid-related damage and alleviating symptoms such as heartburn and acid regurgitation. Zonipraz is typically administered orally, with dosage and duration tailored according to the specific condition and patient response. It is generally well tolerated; however, potential side effects may include headache, diarrhea, nausea, abdominal pain, and, rarely, hypersensitivity reactions. Long-term use should be monitored due to risks of vitamin B12 deficiency, hypomagnesemia, and increased susceptibility to gastrointestinal infections. Caution is advised in patients with hepatic impairment, and drug interactions should be considered, especially with medications requiring an acidic environment for absorption. Zonipraz Tablet should be used under medical supervision to ensure optimal therapeutic outcomes and safety.